SBWire

The Russian apparel market is still attractive to local and international companies as it demonstrates higher volume and value growth compared to Western European markets. This market has not yet reached saturation and the consumption of clothing and footwear per capital is low. The stable economic development of Russia and the potential growth in the size of the middle-class consumer base motivates local and international apparel companies to actively develop their business activities.

Sales of luxury alcohol are growing in the BRICs, as both disposable incomes and alcohol consumption increase. But while the developed countries have similar consumption drivers, this is not the case in the BRICs. Acknowledging cultural diversities and accumulating local knowledge will be crucial for the successful navigation through these markets. Increasing sales will be complicated and will require de-centralised management and resourcing. The gains, though, will be worth the effort.

The written premium of the Portuguese non-life insurance segment decreased during the review period. The decrease was a result of reduced property demand in the domestic market, decreased passenger car sales and limited motor and property insurance demand. The segmental growth was further decelerated by the weak economic development and ongoing sovereign debt crisis in key EU member states. High unemployment levels and a marginal decline in annual disposable income also delayed liability insurance policy sales and discouraged overall growth in the non-life segment. However, the Portuguese government took a number of actions, including an economic stimulus package which aimed to spur the country's economy on and improve macroeconomic fundamentals.

The Macedonian insurance industry is at a nascent stage of development and grew at a CAGR of 2.7% over the course of the review period. The increase is a consequence of strong performance in the life segment which registered a CAGR of 30.5% and is attributed to an increased demand in the domestic market for effective life insurance products. Insurance industry growth was further enhanced by economic development and the demand for international companies to enter the industry.

This report reviews major offshore financial centers and assesses each of their wealth management capabilities. "Wealth management" is defined as the provision of banking services to wealthy individuals and their families. It generally involves the management of trusts, inheritance and the allocation of client funds.

Healthcare organizations have large amounts of data but often do not have the tools to bring the data together for useful business information and planning. Healthcare analytics is the systematic use of data and related business insights developed through applied analytical disciplines such as, statistical, contextual, quantitative, predictive, cognitive, other including emerging model to drive fact-based decision making for planning, management, measurement and learning. Analytics may be descriptive, predictive or prescriptive.

The report covers the global agricultural films market which includes application of the agricultural films, different types of agricultural films, and other related segments. It also studies about the application/end use of the agricultural films with respect to different geographical areas. It also gives the insights about the technology being used; analyses the market with respect to drivers, opportunity, and winning imperatives related to the industry.

BMI View: Canadian IT spending is expected to reach US$45.2bn in 2012, up 1%, with BMI downwardly revising its forecast due to expectations of a macroeconomic cooling in H212. BMI expects Canada's IT market to remain in overall positive growth territory, although much will depend on the business environment. Government spending will continue to be constrained by a focus on cutting costs, with cost reviews being conducted by Toronto and Ontario, but there have been a spate of large tenders, highlighting continued opportunities within the sector. Meanwhile, there will be opportunities as the government seeks to foster the development of a marketplace for cloud services.

The unfavourable economic outlook in Japan, with a real danger of entering recession in 2013 as external demand deteriorates, will make its effects felt across the agribusiness sector. Consumption of pork and beef will grow slowly as household expenditure stagnates, suppressing demand for corn and soybean feed, which will also see declines in response to high prices in global markets. The vast majority of agricultural production in Japan is directed towards domestic consumption as farms are typically small and costs are prohibitively high relative to major exporting countries, so farmers are very dependent on consumers' brittle confidence and their willingness to pay more for Japanese produce. The Agriculture, Forestry and Fisheries Ministry reported in August that self-sufficiency on the basis of intake of calories has fallen to a 17-year low at 39%, highlighting fundamental weaknesses in the sector which may be further exposed if Japan returns to the Trans-Pacific Partnership table.

The accompanying tables present the latest economic data and five-year forecast scenario for the country's banking system. Also included is SWOT analysis of the commercial banking system as a whole.

BMI expects the China consumer electronics market will grow by around 11% in 2012, higher than previously forecast, but still a moderation compared with 2011. Despite the global economic headwinds, Chinese retailers appeared to be optimistic about the outlook for increased sales of flat-screen TV sets and other consumer electronic products in 2012.Vendors will look to newer technologies such as Smart TVs; LED TV sets, which were expected to comprise around 50% of flat-panel sales in 2011; and 3D TV sets, forecast at around 10-20%, to drive sales. A second phase of the government's rural consumer electronics subsidy programme drove sales of computers, flat-screen TV sets and other products in H211. Electronics vendors and retailers were expanding and adjusting strategies to take advantage of this opportunity.

Global Market Direct's pharmaceuticals report, "Alba Therapeutics Corporation - Product Pipeline Review - 2012" provides data on the Alba Therapeutics Corporation's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "MSM Protein Technologies, Inc. - Product Pipeline Review - 2012" provides data on the MSM Protein Technologies, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Markets Direct's, 'Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Peripheral Neuropathy (Sensory Neuropathy), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Peripheral Neuropathy (Sensory Neuropathy). Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Comprising of textual analysis and data tables, this in-depth and exclusive country report from Canadean provides a comprehensive view of the cider industry structure including analysis and profiles on trade mark owners and local operators. Brand volumes and market share are given by price segment, alcoholic strength and type (e.g. apple, pear, flavored). Consumption volumes are provided by pack mix (type, material, refill ability, pack size) and distribution channel (on- and off-premise). Other information includes market valuation/pricing data and new products are identified. All supported by market commentary.

GBI Research's new report, "Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes" provides information and analysis on the major trends and issues affecting biomarkers in the drug discovery process. The report describes the history of biomarkers and their role in fulfilling the unmet needs of the conventional drug discovery process. The drivers and barriers for the biomarkers market, along with the key issues faced in the application of biomarkers in the drug discovery process, are highlighted. The report discusses some important technologies being used in the discovery and validation of biomarkers. The integration of different types of biomarkers in each phase of the drug discovery and development process is also studied. Additionally, the report talks about the strategic consolidations that have taken place within the global biomarkers market. These include mergers, acquisitions, and strategic partnerships among companies involved in the manufacturing of biomarkers for drug discovery and research. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

GBI Research, the leading business intelligence provider, has released its latest research "Hepatitis C Therapeutics Market to 2018 - Expected Launch of GS-7977 in 2015 will Pave the Way for an Oral Interferon-free Combination Therapy", which provides insights into the global hepatitis C therapeutics market up to 2018. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts. The report examines the global hepatitis C treatment usage patterns, and the geographical distribution of hepatitis C therapeutics and markets across the US, the top five countries of Europe and Japan. The report also includes insights into the hepatitis C therapeutics R&D product pipeline and explores the competitive landscape, including major players in the hepatitis C therapeutics market. Finally, the report also includes analysis of the Mergers and Acquisitions (M&As) and licensing agreements that took place in the hepatitis C therapeutics market from 2010 to 2012.

GlobalData, the industry analysis specialist, has released its new report, "Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia". An essential source of information and analysis on the Saudi Arabian healthcare, regulatory, and reimbursement landscape, this report identifies the key trends in the healthcare market, and provides insights on the demographic, regulatory, and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts. In 2011, the population of Saudi Arabia was approximately 28.17 million, growing at an annual rate of 3.8%. The mortality rate was almost steady at approximately four deaths per 1,000 population due to advances in the healthcare infrastructure and medical and diagnostic services. The value of the pharmaceutical market was estimated at $3.5 billion in 2011, and is expected to reach $5.6 billion by 2020, increasing at a projected Compound Annual Growth Rate (CAGR) of 5.4%. The medical device market was worth approximately $1.5 billion in 2011, and is expected to reach $2.3 billion by 2020, increasing at a projected CAGR of 4.5%.

Global Market Direct's pharmaceuticals report, "D-Pharm Ltd. - Product Pipeline Review - 2012" provides data on the D-Pharm Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Markets Direct's, 'Bacteremia - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Bacteremia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bacteremia. Bacteremia - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Market Direct's pharmaceuticals report, "Medesis Pharma S.A. - Product Pipeline Review - 2012" provides data on the Medesis Pharma S.A.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "Shenzhen Beike Biotechnology Co., Ltd. - Product Pipeline Review - 2012" provides data on the Shenzhen Beike Biotechnology Co., Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Markets Direct's, 'Secondary Hyperparathyroidism - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Secondary Hyperparathyroidism, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Secondary Hyperparathyroidism. Secondary Hyperparathyroidism - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Seo4anyone provides result-oriented SEO services for both large and small local businesses. Their services include search engine optimization (SEO), pay per click management (PPC), social media marketing (Facebook Twitter, Youtube, LinkedIn), viral marketing strategies, landing page conversion testing (A/B Testing), website optimization testing, email marketing and website design.

Neron Solutions is best professional Web Design & SEO Company in UK having expert web designers & developers offers services like Web Designing, Website Development, SEO Services, Applications development